Literature DB >> 215321

Metabolism of acetylcholine receptor in chick embryo muscle cells: effects of RSV and PMA.

R Miskin, T G Easton, A Maelicke, E Reich.   

Abstract

We have investigated some aspects of the metabolism of the integral membrane protein acetylcholine receptor (AChR) in normal and transformed cultures of chick embryo muscle cells. Turnover of AChR in control muscle cell cultures was compared with turnover in cultures infected and transformed by a temperature-sensitive mutant of Rous sarcoma virus (RSV) and with cultures treated with the tumor promoter phorbol myristate acetate (PMA). The parameters of AChR metabolism were estimated using 125I-alpha-bungarotoxin as a stoichiometric high affinity ligand for the AChR. We found that both RSV transformation and PMA increased the rate of degradation and decreased the rate of synthesis of AChR. The consequent reduction in steady state receptor levels suggests that oncogenic transformation and tumor promoter significantly alter the metabolism of cell surface membranes. We also observed that parameters of AChR metabolism in control cultures changed systematically in a pattern which depended upon the age of the culture as well as the use of embryo extract or fetal bovine serum as medium supplements. The muscle cell system allows quantitative measurement of an integral membrane protein and its metabolism, and may serve as a more general model for alterations in membrane and surface receptor metabolism associated with the transformed state.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215321     DOI: 10.1016/0092-8674(78)90054-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  14 in total

1.  Spontaneous channel activity induced by tumor promoter TPA in chick myotubes.

Authors:  C Ciccarelli; B M Zani; M Molinaro; F Grassi; F Eusebi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

2.  Differential effects of transforming avian RNA tumor viruses on avian macrophages.

Authors:  E M Durban; D Boettiger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

3.  Affinity chromatography and immunosorption with acetylcholine receptor attached to nylon tubes.

Authors:  B H Yang; P V Sundaram; A Maelicke
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

4.  Transformation by Rous sarcoma virus prevents acetylcholine receptor clustering on cultured chicken muscle fibers.

Authors:  D T Anthony; S M Schuetze; L L Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Inhibition of muscle differentiation by trypanosoma cruzi.

Authors:  K S Rowin; H B Tanowitz; M Wittner; H T Nguyen; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Selective effects of phorbol 12-myristate 13-acetate on myofibrils and 10-nm filaments.

Authors:  J Croop; Y Toyama; A A Dlugosz; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture.

Authors:  J M Prives; K Olden
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.

Authors:  B W Fulpius; R Miskin; E Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells.

Authors:  J L Gross; M N Krupp; D B Rifkin; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

10.  Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

Authors:  G Grimaldi; P Di Fiore; E K Locatelli; J Falco; F Blasi
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.